CAMBRIDGE, Mass., Feb. 5, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that
Adelene Perkins, Infinity
Pharmaceutical's chief executive officer, will present at the BIO
CEO & Investor Conference on Monday,
February 12, 2018, at 11:00 a.m.
EST at The New York Marriott in New York, NY. A live webcast of the
presentation will be available on the Investors/Media section of
Infinity's website at www.infi.com, and will be available for 30
days following the event.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel medicines
for people with cancer. Infinity is advancing IPI-549, an oral
immuno-oncology development candidate that selectively inhibits
PI3K-gamma. A Phase 1/1b study in
approximately 200 patients with advanced solid tumors is ongoing.
For more information on Infinity, please refer to Infinity's
website at www.infi.com.
Contact:
Stephanie
Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original
content:http://www.prnewswire.com/news-releases/infinity-to-present-at-bio-ceo--investor-conference-300590611.html
SOURCE Infinity Pharmaceuticals, Inc.